Kentucky Equine Drug Research Council

Santa Anita To Install Prototype Data-Gathering Technology On Track Maintenance Equipment

During Wednesday night’s “Racing Surfaces” panel discussion hosted by the University of Louisville’s Equine Industry Program, Dr. Mick Peterson revealed he is working closely with Santa Anita in the lead up to the Breeders’ Cup to install new prototypes of data-gathering technology on the track maintenance equipment. The director of the University of Kentucky Ag […]

Continue reading
Dr. Mary Scollay New Executive Director, COO Of Racing Medication And Testing Consortium

The Racing Medication and Testing Consortium (RMTC) has hired Dr. Mary Scollay as its next executive director and chief operating officer. In her new role, which she assumes August 5, Dr. Scollay will be charged with the advancement of world-class laboratory drug testing standards, promotion of RMTC-recommended rules and penalties for prohibited substances and therapeutic […]

Continue reading
EPO: What We Know, And What We Don’t, About The Blood-Doping Threat

When Lance Armstrong confessed in 2013 to taking Epogen to boost production of oxygen-carrying red blood cells, horse racing fans began looking behind every tree for the boogeyman called erythropoietin, or EPO. Many had long suspected EPO had risen to prominence in horse racing in the 1990s alongside anabolic steroids, and news that one of […]

Continue reading
Kentucky Racing Commission Funding Two-Year Research Project On Inflammatory Biomarkers

The Kentucky Horse Racing Commission recently voted unanimously to fund a project at the University of Kentucky Maxwell H. Gluck Equine Research Center examining inflammatory and anti-inflammatory markers as early indicators for potential catastrophic (life-ending) injury in racehorses. The occurrence of injuries in horses and jockeys during training and racing is a significant economic and welfare concern […]

Continue reading
The Trouble With Aminorex

Aminorex has already caused a few headaches for regulators. If a recent Kentucky Equine Drug Research Council (EDRC) meeting is any indication, it’s destined to have a few more reaching for the aspirin. Aminorex is a stimulant that was once available in the human market as a weight loss aid. It was pulled from sale […]

Continue reading
Equine Biological Passports: Years Away, But Receiving Industry Support

The Kentucky Equine Drug Research Council (KEDRC) unanimously voted this week to allocate $15,000 to funding ongoing research into biological passport. Although the technology is at least a couple of years from implementation, Dr. Scott Stanley of the University of California-Davis said the passports could solve several problems in drug testing. Regulators face particular challenges […]

Continue reading
Bramlage: ‘Price To Pay’ For Bisphosphonate Use Is Delayed Healing

“I wish we’d never seen these drugs,” said renowned orthopedic surgeon Dr. Larry Bramlage at the conclusion of a recent presentation about bisphosphonates. Four years after the Food and Drug Administration approved the use of Tildren and Osphos (both trade names for bisphosphonates) for use in adult horses suffering from navicular syndrome, Bramlage said he’s […]

Continue reading
Study Of Inflammatory Markers Leaves Researchers With More Questions About Predicting Racehorse Injury

For years now, researchers have been searching for some kind of agent detectable in horses’ blood to warn them of an impending injury. Research presented by Dr. David Horohov of the Gluck Equine Research Center at the University of Kentucky at a recent Kentucky Equine Drug Research Council meeting shows the quest has continued to […]

Continue reading
Study Suggests Need For Another Revision To Uniform Drug Guidelines

Recommended withdrawal guidelines for detomidine, commercially known as Dormosedan, may face review after a recent study suggested horses could test positive while adhering to the withdrawal guidelines, depending on the dose they receive. The current guideline from the Racing Medication Testing Consortium suggests the threshold for a positive be set at 2ng/ml in urine and […]

Continue reading
Kentucky One Step Closer To Uniform Medication Rules With Council Vote

Kentucky regulators came a step closer to bringing the state’s regulations in line with the National Uniform Medication Program (NUMP) on Tuesday afternoon when the Kentucky Equine Drug Research Council voted to approve drug classifications, penalty schedules, withdrawal guidelines and thresholds set out by the Racing Medication and Testing Consortium. Kentucky has been partially in line […]

Continue reading
Twitter Twitter
Paulick Report on Instagram